NR1H4 and malignant colon neoplasm: The discovery of the role of bile acid receptors in a number of diseases, including cholangiocarcinoma, hepatocellular carcinoma, and colon cancer, has led to the development of novel receptor agonists for potential treatments and therapies (41).